Pharma & Biotech News #PharmaBuzz

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Weekly News Recap #Phispers

GSK acquires Nuvalent for US$ 10.6 bn to expand its oncology portfolio; Roche inks up to US$ 2.3 bn deal with Nurix

This week, Phispers brings you several developments in the field of oncology. One, GSK acquired a Boston-based clinical-stage b...

Impressions : 708

FDA approves Wockhardt's antibiotic for complicated UTIs; Pfizer inks up to US$ 10.5 billion deal with Innovent

This week’s Phispers is full of news about deals and clinical trials emerging out of the recently concluded annual meetin...

Impressions : 980

Lilly buys three vaccine drugmakers in deals worth up to US$ 3.8 bn; FDA approves AbbVie's ultra rare blood cancer drug

Buoyed by the rising sales of its obesity drug, Eli Lilly has been on an acquisition spree this year. The company announced ag...

Impressions : 1537

FDA issues warning letter to Chinese supplier of semaglutide; approves AstraZeneca's new treatment for hypertension

In Phispers this week, the US Food and Drug Administration (FDA) approved AstraZeneca’s first-in-class treatment for hype...

Impressions : 2297

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

GSK acquires Nuvalent for US$ 10.6 bn to expand its oncology portfolio; Roche inks up to US$ 2.3 bn deal with Nurix

FDA approves Wockhardt's antibiotic for complicated UTIs; Pfizer inks up to US$ 10.5 billion deal with Innovent

Lilly buys three vaccine drugmakers in deals worth up to US$ 3.8 bn; FDA approves AbbVie's ultra rare blood cancer drug

FDA issues warning letter to Chinese supplier of semaglutide; approves AstraZeneca's new treatment for hypertension

Yaopharma's Generics Tofacitinib Receives Approval in US

Aon Pharma's Generics Xeljanz Receives Approval in US

Radiomedix's Generics Gallium Gozetotide Receives Approval in US

Teva Pharms' Generics Macitentan Receives Approval in US

Zenara's Generics Gadobutrol Receives Approval in US

Hibrow Hlthcare's Generics Ramelteon Receives Approval in US

MSN Pharma's Generics Cangrelor Receives Approval in US

Be Pharms' Generics Dalbavancin HCl Receives Approval in US

Alembic's Generics Haloperidol Receives Approval in US

Macleods' Generics Tofacitinib Citrate Receives Approval in US

Erkul Kozmetik Sanayi ve Ticaret AS's Receives FDA Warning Letter

Asanuma Corporation Sagamihara's Receives FDA Warning Letter

Laboratorios Dr Collado S A's Receives FDA Warning Letter

Shantou Qiwei Industry's Receives FDA Warning Letter

Hubei Gedian Humanwell's Receives FDA Warning Letter

Zydus Lifesciences' Receives FDA Warning Letter

Gopaldas Visram's Receives FDA Warning Letter

Jose M Carpio's Receives FDA Warning Letter

Umendra Life's Receives FDA Warning Letter

Revlon Group's Receives FDA Warning Letter

Spyre says Bowel Disease Drug cuts Inflammation in mid-stage

Novartis India launches Pluvicto for prostate cancer treatment

Neumora abandons depression candidate, axes staff

Lonza, Antharis partner to develop next-generation ADCs

Harbour BioMed Wins $20 Million Patent Verdict Against Amgen

Elicio's KRAS cancer vaccine fails in Phase 2, shares plummet

Adaptive Biotech plans separation of immune medicine platform

Baby formula maker Nara issues US-wide recall after FDA

Novo Nordisk to seek approval soon to sell Wegovy pill in China

Dr Reddy's launches first-to-market generic Bosutinib in US

Dr Reddy's launches first-to-market generic Bosutinib in US

India Raises Price Cap on Cancer Drugs to Tackle Shortage

Cosmos Health Gets New Contract Orders for 253,657 Units

FDA OKs Emergency Use of OTC Drug for Screwworm in Pets

Astellas CEO's 5-Year Plan to Counter Xtandi Patent Cliff

Alembic Gets USFDA Tentative Approval for Larotrectinib ANDA

RadioMedix Gets FDA Approval for Generic Ga-68 PSMA-11

Hetero, Richter Partner to Develop, Market Semaglutide

Cosmos's 3-Year Deal With Verisfield for Progesterone Pessaries

Takeda Faces $2.5B Hit from Amitiza Antitrust Verdict

Spyre says Bowel Disease Drug cuts Inflammation in mid-stage

Novartis India launches Pluvicto for prostate cancer treatment

Neumora abandons depression candidate, axes staff

Lonza, Antharis partner to develop next-generation ADCs

Harbour BioMed Wins $20 Million Patent Verdict Against Amgen

Elicio's KRAS cancer vaccine fails in Phase 2, shares plummet

Adaptive Biotech plans separation of immune medicine platform

Novo Nordisk to seek approval soon to sell Wegovy pill in China

Lundbeck drug candidate shows promise in Cushing's disease trial

Traws Pharma Provides Regulatory Update on Influenza Program

Symeres Expands Spray Drying Capabilities in New Jersey

Axplora consolidates global UDCA manufacturing at Vizag facility

Teva To Cut 250 Jobs At API Unit Amid Prolonged Owner Search

CBC India & Metalco-Alupack sign exclusive strategic partnership

TDB Supports Indigenous Production of Green Pharma Ingredients

PharmaBlock's First Peptide GMP Pilot Plant Now Operational

Niner Pharma Expands Global Peptide and Oncology API Network

Intracin Pharma Gets Australian APVMA Approval for Vet Medicines

Strategic API Sourcing: Building Supply Chain Resilience

NPPA Revises Injectable Antibiotic Price Ceiling Following Review

Baby formula maker Nara issues US-wide recall after FDA

FDA Imposes Import Alert on Indian Plant over GMP Failings

Novo Hit by Cybersecurity Breach, Urges Trial Vigilance

Medline Issues Correction for Bupivacaine HCl Injection Kits

Health Ministry Appoints 22 Drug Inspectors for Devices

Beekeeper's Naturals Recalls Saline Nasal Spray for Contamination

Novo Reports Data Breach, Tells Trial Patients to Stay Alert

US Drug Regulator Issues Import Alert for Dabur India Plant

Camurus Gets Second CRL for Acromegaly Drug; Teva Cuts Jobs

Reacta Healthcare Gets Extended MHRA Manufacturer Certificate

Profusa Submits CE Mark Response for Lumee Oxygen Platform

21 Countries Launch Coordinated Andes Virus Research Push

NIH Grant to Fund Innovative Bladder Repair for Children